Doi.org/10.1093/inthealth/ihx038

Target ArticleEdit

For as long as necessary: examining 30 years of Merck & Co., Inc.’s focus on achieving elimination of onchocerciasis and lymphatic filariasis  ; Kenneth M Gustavsen Brenda D Colatrella Theresa McCoy; NULL; 11/23/2017; https://doi.org/10.1093/inthealth/ihx038

ReasonsEdit

Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.